Publications
-
Arimany-Nardi C, Montraveta A, Lee-Vergés E, Puente XS, Koepsell H, Campo E, Colomer D and Pastor-Anglada M.
Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells
PHARMACOGENOMICS JOURNAL . 15(4): 363-371. Number of citations: 16
-
Claudio-Montero A, Pinilla-Macua I, Fernández-Calotti P, Sancho-Mateo C, Lostao MP, Colomer D, Grandas A and Pastor-Anglada M.
Fluorescent Nucleoside Derivatives as a Tool for the Detection of Concentrative Nucleoside Transporter Activity Using Confocal Microscopy and Flow Cytometry
MOLECULAR PHARMACEUTICS . 12(6): 2158-2166. Number of citations: 8
-
Urtasun N, Vidal-Pla A, Perez-Torras S and Mazo A.
Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors
BMC Cancer . 15: 223-223. Number of citations: 19
-
Minami K, Shinsato Y, Yamamoto M, Takahashi H, Zhang S, Nishizawa Y, Tabata S, Ikeda R, Kawahara K, Tsujikawa K, Chijiiwa K, Yamada K, Akiyama S, Perez-Torras S, Pastor-Anglada M, Furukawa T and Yasuo T.
Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
JOURNAL OF PHARMACOLOGICAL SCIENCES . 127(3): 319-325. Number of citations: 46
